Secondary Prevention of Atherothrombotic Cerebrovascular Events

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|12|3|365-372

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.12, Iss.3, 2014-01, pp. : 365-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial

By  

Current Vascular Pharmacology, Vol. 13, Iss. 6, 2015-10 ,pp. : 809-10

Bentham Science Publishers

Access to resources Recommend Favorite

Triflusal and Aspirin in the Secondary Prevention of Atherothrombotic Ischemic Stroke: A Very Long-Term Follow-Up

By  

Cerebrovascular Diseases, Vol. 37, Iss. 3, 2014-02 ,pp. : 181-187

Karger

Access to resources Recommend Favorite

Clopidogrel for Cerebrovascular Prevention

By  

Cerebrovascular Diseases, Vol. 9, Iss. 5, 1999-09 ,pp. : 253-260

Karger

Access to resources Recommend Favorite

Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-05 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population

By  

Cerebrovascular Diseases, Vol. 27, Iss. 6, 2009-04 ,pp. : 608-613

Karger

Access to resources Recommend Favorite